SCHEMBL5720410

SCHEMBL5720410

ClC(Cl)(Cl)c1c2ccccc2nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.56
▸ MAOB P27338 1/20 0.56
▸ KDM4E B2RXH2 6/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ GLA P06280 4/20 0.50
▸ HPGD P15428 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ CASP1 P29466 2/20 0.50
▸ CASP7 P55210 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ CHRM2 P08172 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ CHRM1 P11229 1/20 0.50
▸ NQO2 P16083 1/20 0.50
▸ DRD1 P21728 1/20 0.50
▸ ACHE P22303 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ ADRA1A P35348 1/20 0.50
▸ OPRM1 P35372 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1538664 0.79 TSHR (0.45) MAOAMAOBALDH1A1HPGDHSD17B10
SCHEMBL5720497 0.78 KDM4E (0.52) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL13222013 0.76 ATM (0.55) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL28091119 0.73 KMT2A (0.48) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL455949 0.72 MAOA (1.00) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL17423367 0.72 KDM4E (0.56) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL13445183 0.72 KDM4E (0.56) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL27889436 0.72 MAOA (1.00) MAOAMAOBKDM4EALDH1A1GLA
SCHEMBL1502392 0.71 ALDH1A1 (0.62) MAOAMAOBKDM4EALDH1A1GLA
Hydrochloric Acid SCHEMBL28400797 0.70 MAOA (0.95) MAOAMAOBKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 — — US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 — — US disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 — — US disclosed
EP-1072576-B1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2006-08-02 — — EP disclosed
US-6417361-B1 HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND MITSUI CHEMICALS, INC. (JP) 2002-07-09 — — US disclosed
CN-1294568-A Fluorinating agent, process for producing same, and use thereof MITSUI CHEMICALS INC (JP) 2001-05-09 — — CN disclosed
EP-1072576-A1 FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2001-01-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 MAOA 2625/4885MAOB 3638/4885KDM4E 2254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback